secwatch.observer — SEC 8-K summary
======================================

Issuer:     CARDINAL HEALTH INC (CAH)
CIK:        0000721371
Form:       8-K
Filed at:   2026-04-30T23:59:59+00:00
Accession:  0000721371-26-000017
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cardinal Health Q3 revenue +11% to $60.9B, non-GAAP EPS $3.17 (+35%), raises FY26 outlook
--------------------------------------------------------------------------------

- Non-GAAP EPS $3.17, up 35% YoY; GAAP EPS $1.69, down 20% on $184M goodwill impairment in Navista & ION.
- Revenue $60.9B, +11%; Pharmaceutical & Specialty segment profit +18% to $784M.
- FY26 non-GAAP EPS guidance raised to $10.70-$10.80; adjusted free cash flow raised to $3.3B-$3.7B.
- Global Medical segment profit fell 36% to $25M due to tariff impact; Other segment profit up 34% to $179M.
- Completed $250M accelerated share repurchase; YTD buybacks $1.0B; leverage ratio lowered to 3.0X.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/721371/000072137126000017/0000721371-26-000017-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/721371/000072137126000017/cah-20260430.htm
  HTML page:      https://secwatch.observer/filing/0000721371-26-000017

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer